|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2008-10-6
|
|
pubmed:abstractText |
Osteonecrosis of the jaw (ONJ) is a severe complication of bisphosphonates treatment. Bisphosphonates reduce skeletal adverse events and give a clinical benefit to cancer patients. Therefore, it is necessary to identify appropriate procedures to reduce ONJ injures by using a successful monitoring program. In a retrospective study we analyzed the impact of a prevention program based on clinical oral cavity examination, dentists, and patients' education. The aim of the study was to evaluate if this approach might improve ONJ outcome in patients receiving pamidronate or zoledronate.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0941-4355
|
|
pubmed:author |
pubmed-author:BareggiClaudiaC,
pubmed-author:BianchiCelsoC,
pubmed-author:BorgonovoKarenK,
pubmed-author:CobelliStefanoS,
pubmed-author:FarinaGabriellaG,
pubmed-author:GarassinoMarinaM,
pubmed-author:La VerdeNiclaN,
pubmed-author:ManticaCristinaC,
pubmed-author:MihaliDorianD,
pubmed-author:PedrettiDonataD,
pubmed-author:PerroneSilviaS,
pubmed-author:RizzoAuroraA,
pubmed-author:SburlatiPaolaP
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1311-5
|
|
pubmed:meshHeading |
pubmed-meshheading:18663482-Aged,
pubmed-meshheading:18663482-Antineoplastic Agents,
pubmed-meshheading:18663482-Bone Density Conservation Agents,
pubmed-meshheading:18663482-Bone Neoplasms,
pubmed-meshheading:18663482-Diphosphonates,
pubmed-meshheading:18663482-Female,
pubmed-meshheading:18663482-Health Knowledge, Attitudes, Practice,
pubmed-meshheading:18663482-Humans,
pubmed-meshheading:18663482-Imidazoles,
pubmed-meshheading:18663482-Incidence,
pubmed-meshheading:18663482-Italy,
pubmed-meshheading:18663482-Jaw Diseases,
pubmed-meshheading:18663482-Male,
pubmed-meshheading:18663482-Osteonecrosis,
pubmed-meshheading:18663482-Retrospective Studies,
pubmed-meshheading:18663482-Risk Factors
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Osteonecrosis of the jaw (ONJ) in cancer patients treated with Bisphosphonates: how the knowledge of a phenomenon can change its evolution.
|
|
pubmed:affiliation |
Oncology Department, Azienda Ospedaliera-Ospedale Fatebenefratelli e Oftalmico, Milan, Italy. nicla.laverde@fbf.milano.it
|
|
pubmed:publicationType |
Journal Article
|
